Genital Dysbiosis and Different Systemic Immune Responses Based on the Trimester of Pregnancy in SARS-CoV-2 Infection
- PMID: 38673883
- PMCID: PMC11050260
- DOI: 10.3390/ijms25084298
Genital Dysbiosis and Different Systemic Immune Responses Based on the Trimester of Pregnancy in SARS-CoV-2 Infection
Abstract
Respiratory infections are common in pregnancy with conflicting evidence supporting their association with neonatal congenital anomalies, especially during the first trimester. We profiled cytokine and chemokine systemic responses in 242 pregnant women and their newborns after SARS-CoV-2 infection, acquired in different trimesters. Also, we tested transplacental IgG passage and maternal vaginal-rectal microbiomes. IgG transplacental passage was evident, especially with infection acquired in the first trimester. G-CSF concentration-involved in immune cell recruitment-decreased in infected women compared to uninfected ones: a beneficial event for the reduction of inflammation but detrimental to ability to fight infections at birth. The later the infection was acquired, the higher the systemic concentration of IL-8, IP-10, and MCP-1, associated with COVID-19 disease severity. All infected women showed dysbiosis of vaginal and rectal microbiomes, compared to uninfected ones. Two newborns tested positive for SARS-CoV-2 within the first 48 h of life. Notably, their mothers had acute infection at delivery. Although respiratory infections in pregnancy are reported to affect babies' health, with SARS-CoV-2 acquired early during gestation this risk seems low because of the maternal immune response. The observed vaginal and rectal dysbiosis could be relevant for neonatal microbiome establishment, although in our series immediate neonatal outcomes were reassuring.
Keywords: COVID-19; SARS-CoV-2; dysbiosis; dysimmunity; pregnancy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Maternal-Fetal Outcomes and Antibody Transfer, Depending on the Trimester of SARS-CoV-2 Infection in Non-Vaccinated Women-A Danish Nationwide Prospective Cohort Study.Int J Mol Sci. 2025 Mar 12;26(6):2533. doi: 10.3390/ijms26062533. Int J Mol Sci. 2025. PMID: 40141174 Free PMC article.
-
Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978. doi: 10.1002/uog.23639. Ultrasound Obstet Gynecol. 2021. PMID: 33798280 Free PMC article.
-
Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2.JAMA Netw Open. 2021 Nov 1;4(11):e2132563. doi: 10.1001/jamanetworkopen.2021.32563. JAMA Netw Open. 2021. PMID: 34730817 Free PMC article.
-
Neurodevelopmental implications of COVID-19-induced gut microbiome dysbiosis in pregnant women.J Reprod Immunol. 2024 Sep;165:104300. doi: 10.1016/j.jri.2024.104300. Epub 2024 Jul 11. J Reprod Immunol. 2024. PMID: 39004033 Review.
-
An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.Arch Pathol Lab Med. 2020 Jul 1;144(7):799-805. doi: 10.5858/arpa.2020-0901-SA. Arch Pathol Lab Med. 2020. PMID: 32180426 Review.
References
-
- Dallmann A., Ince I., Meyer M., Willmann S., Eissing T., Hempel G. Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy. Clin. Pharmacokinet. 2017;56:1303–1330. doi: 10.1007/s40262-017-0539-z. - DOI - PubMed
-
- Hu X., Gao J., Luo X., Feng L., Liu W., Chen J., Benachi A., de Luca D., Chen L. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers with Coronavirus Disease 2019 (COVID-19) Pneumonia. Obstet. Gynecol. 2020;136:65–67. doi: 10.1097/AOG.0000000000003926. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous